A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

NCT01943084 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Disorder
Healthy

Interventions

DRUG: Norditropin® FlexPro® pen
DRUG: Genotropin Pen®

Sponsor

Novo Nordisk A/S